CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,835,873 | -9.7% | 2,574,198 | 0.0% | 1.60% | +0.1% |
| Q2 2023 | $83,970,339 | -7.3% | 2,574,198 | 0.0% | 1.60% | -15.2% |
| Q1 2023 | $90,586,028 | -23.2% | 2,574,198 | 0.0% | 1.89% | -21.7% |
| Q4 2022 | $117,949,752 | -5.4% | 2,574,198 | 0.0% | 2.41% | -16.2% |
| Q3 2022 | $124,720,000 | +23.9% | 2,574,198 | +0.5% | 2.88% | +10.6% |
| Q2 2022 | $100,629,000 | +6.7% | 2,561,182 | 0.0% | 2.60% | +33.3% |
| Q1 2022 | $94,277,000 | -19.2% | 2,561,182 | 0.0% | 1.95% | +14.4% |
| Q4 2021 | $116,739,000 | +63.3% | 2,561,182 | +28.1% | 1.70% | +58.2% |
| Q3 2021 | $71,480,000 | +80.6% | 2,000,000 | 0.0% | 1.08% | +80.6% |
| Q2 2021 | $39,580,000 | -14.9% | 2,000,000 | 0.0% | 0.60% | -17.8% |
| Q1 2021 | $46,520,000 | +12.6% | 2,000,000 | 0.0% | 0.73% | +4.8% |
| Q4 2020 | $41,311,000 | +1.5% | 2,000,000 | 0.0% | 0.69% | -29.3% |
| Q3 2020 | $40,702,000 | – | 2,000,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |